|
|
2711 Citrus Road
Rancho Cordova, CA 95742 USA
phone:(916) 858-5100
fax:(916) 858-5199
|
|
| Symbol |
KOOL |
| Exchange |
NasdaqCM |
| Founded |
1986 |
| Employees |
76 |
|
|
| www.thermogenesis.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Develops technologies that address Stem Cell Processing and Cryopreservation. |
|
| Management |
| J. Melville Engle, Chairman & CEO;
Matthew Plavan, CFO, EVP, Business Development;
Jorge Artiles, Vice President, Chief Quality and Regulatory Affairs Officer;
Karen Auditore-Hargreaves, Ph.D., Vice President of Scientific Affairs; Harold (Hal) Baker, Vice President of Commercial Operations; Kevin D. Cooksy, Vice President of Business Development; Kenneth A. Pappa, Vice President of Engineering and Manufacturing |
| |
|
|
|
|
|
|
| Recent Results |
| For the quarter ended March 31, 2011, the Company reported revenues of $5.2 million, an increase of 8% versus revenues of $4.8 million in the third quarter a year ago and $5.9 million in the prior quarter. Disposable revenues in the third quarter of fiscal 2011 were $3.0 million, consistent with those in the third quarter of fiscal 2010. |
| |
|
|
|
|
| Keywords |
| cryopreservation, MarrowXpress, Res-Q, stem cell, cellular tissue, regenerative medicine, bone marrow |
|
|
|
| Description |
|
ThermoGenesis targets the adult stem cell market in the US and Europe by providing physicians, researchers, hospitals, and blood banks with a wide range of cell-based systems. The Company offers automated devices, semi-automated devices, and single-use processing disposables that enable the collection, processing, and cryopreservation of stem cells and other cellular tissues from cord blood and bone marrow. Stem cells are put to use in the practice of regenerative medicine, a field that uses cell-based therapies to repair or restore lost or damaged tissue and cell function. ThermoGenesis also provides the rapid preparation of autologous surgical sealants for wound care, as well as state-of-the-art blood-component thawing and freezing systems. As of June 2011, ThermoGenesis has received FDA clearance to use its Res-Q™ 60 System technology for the safe and rapid preparation of autologous platelet-rich plasma that is derived from a small sample of blood at the patient’s point-of-care, providing a significant new market opportunity for this later-stage medical device company. |
|
| Products / Services |
The Company's core offerings include the AXP AutoXpress Platform for processing of cord blood; and BioArchive System, an automated cryogenic device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant. Its offerings also include MXP MarrowXpress, which is used for isolating stem cells from bone marrow, and the Res-Q 60 BMC, a point-of-care bone marrow stem cell processing system.
|
|
|
|
|
| |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
